lyophilized human blood coagulation factor viii

Italy

Drugs containing this active substance

  • EMOCLOT

    It is used for the treatment and prevention of bleeding in people with hemophilia A (a hereditary deficiency of factor VIII) or in patients with factor VIII deficiency caused by other diseases. It is also used for those who have developed antibodies (inhibitors) against factor VIII.

    Form: solution for infusion, powder and solvent for preparation

    Active substance Dosage
    lyophilized human blood coagulation factor viii -

    ATC: B02BD02

    Manufacturer: KEDRION S.P.A.

  • EMOWIL

    It is used to treat bleeding in patients with hemophilia A (a hereditary deficiency of factor VIII), in patients with factor VIII deficiency caused by other diseases, in people with von Willebrand disease, and in hemophilic patients who have developed antibodies against factor VIII (inhibitors).

    Form: solution for injection, powder and solvent

    Active substance Dosage
    lyophilized human blood coagulation factor viii -

    ATC: B02BD02

    Manufacturer: KEDRION S.P.A.

  • FANHDI

    Fanhdi is used for the treatment and prevention of bleeding episodes in people with hemophilia A (factor VIII deficiency) or von Willebrand disease (when desmopressin treatment is ineffective or contraindicated). It is also indicated for the treatment of acquired factor VIII deficiency and for hemophiliacs A who have antibodies against factor VIII.

    Form: solution for injection, powder and solvent

    Active substance Dosage
    lyophilized human blood coagulation factor viii -
    von willebrand factor -

    ATC: B02BD06

    Manufacturer: INSTITUTO GRIFOLS S.A.